Faldaprevir Plus Pegylated Interferon Alfa-2a and Ribavirin in Chronic HCV Genotype-1 Treatment-Naive Patients: Final Results from STARTVerso1: A Randomized, Double-blind, Placebo-Controlled, Phase 3 Trial

Morano Amado, Luis

Statistics

Statistics

View Usage Statistics

Identifiers

Identifiers

URI: http://hdl.handle.net/20.500.11940/2349

DOI: 10.1038/ajg.2013.265

ISSN: 0002-9270

Full record

Services

Services

RIS

Mendeley

Linksolver

Date issued

2013

Journal title

AMERICAN JOURNAL OF GASTROENTEROLOGY

Type of content

Publicación de congreso